期刊
AUTOPHAGY
卷 9, 期 2, 页码 255-257出版社
LANDES BIOSCIENCE
DOI: 10.4161/auto.22738
关键词
sorafenib; multiple myeloma; 5T33MM; autophagy; bone marrow stroma; ABT737; cell death; tyrosine kinase inhibitor
类别
Multiple myeloma (MM) comprises 1% of all malignancies and 10% of all hematological malignancies. MM is a malignancy of plasma cells in the bone marrow where complex and dynamic interactions with the bone marrow microenvironment lead to tumor progression, skeletal destruction and angiogenesis. Despite the discovery of several novel treatments against MM, including the proteasome inhibitor bortezomib, it is considered to be an incurable disease with an average 4-5 years overall survival.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据